钠-葡萄糖共转运蛋白 2 抑制剂的美国保险计划类型的覆盖范围、处方限制和可负担性。
Coverage, Formulary Restrictions, and Affordability of Sodium-Glucose Cotransporter 2 Inhibitors by US Insurance Plan Types.
机构信息
Division of Healthcare Delivery Science and Innovation, Department of Population Health Sciences, Weill Cornell Medicine, New York, New York.
Division of Cardiology and Kidney Health Research Collaborative, University of California, San Francisco.
出版信息
JAMA Health Forum. 2021 Dec 17;2(12):e214205. doi: 10.1001/jamahealthforum.2021.4205. eCollection 2021 Dec.
Abstract
This cross-sectional study evaluates the stipulations of coverage under commercial, health insurance exchange, Veterans Affairs, Medicare, Medicaid, or other insurance for canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin.
摘要
本横断面研究评估了商业保险、医疗保险交易所、退伍军人事务部、医疗保险、医疗补助或其他保险对卡格列净、达格列净、恩格列净和埃格列净的覆盖规定。
Zotero 插件